Literature DB >> 23230215

Sex, pain, and opioids: interdependent influences of sex and pain modality on dynorphin-mediated antinociception in rats.

Nai-Jiang Liu1, Stephen Schnell, Martin W Wessendorf, Alan R Gintzler.   

Abstract

The role of dynorphin A (1-17; Dyn) and its associated kappa opioid receptor (KOR) in nociception represents a longstanding scientific conundrum: Dyn and KOR (Dyn/KOR) have variously been reported to inhibit, facilitate, or have no effect on pain. We investigated whether interactions between sex and pain type (which are usually ignored) influenced Dyn/KOR-mediated antinociception. Blockade of the spinal α(2)-noradrenergic receptor (α(2)-NAR) using yohimbine elicited comparable spinal Dyn release in females and males. Nevertheless, the yohimbine-induced antinociception exhibited sexual dimorphism that depended on the pain test used: in the intraperitoneal acetic acid-induced writhing test, yohimbine produced antinociception only in females, whereas in the intraplantar formalin-induced paw flinch test, antinociception was observed only in males. In females and males, both intrathecal Dyn antibodies and spinal KOR blockade eliminated the yohimbine-induced antinociception, indicating that Dyn/KOR mediated it. However, despite the conditional nature of spinal Dyn/KOR-mediated yohimbine antinociception, both intraplantar formalin and intraperitoneal acetic acid activated spinal Dyn neurons that expressed α(2)-NARs. Moreover, Dyn terminals apposed KOR-expressing spinal nociceptive neurons in both sexes. This similar organization suggests that the sexually dimorphic interdependent effects of sex and pain type may result from the presence of nonfunctional (silent) KORs on nociceptive spinal neurons that are responsive to intraplantar formalin (in females) versus intraperitoneal acetic acid (in males). Our findings that spinal Dyn/KOR-mediated antinociception depends on interactions between sex and pain type underscore the importance of using both sexes and multiple pain models when investigating Dyn/KOR antinociception.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23230215     DOI: 10.1124/jpet.112.199851

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

Review 1.  Arbiters of endogenous opioid analgesia: role of CNS estrogenic and glutamatergic systems.

Authors:  Alan R Gintzler; Nai-Jiang Liu
Journal:  Transl Res       Date:  2021-02-07       Impact factor: 7.012

2.  Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females.

Authors:  Cindee F Robles; Marissa Z McMackin; Katharine L Campi; Ian E Doig; Elizabeth Y Takahashi; Michael C Pride; Brian C Trainor
Journal:  Behav Brain Res       Date:  2014-01-18       Impact factor: 3.332

Review 3.  Qualitative sex differences in pain processing: emerging evidence of a biased literature.

Authors:  Jeffrey S Mogil
Journal:  Nat Rev Neurosci       Date:  2020-05-21       Impact factor: 34.870

4.  Estrogens Suppress Spinal Endomorphin 2 Release in Female Rats in Phase with the Estrous Cycle.

Authors:  Arjun Kumar; Emiliya M Storman; Nai-Jiang Liu; Alan R Gintzler
Journal:  Neuroendocrinology       Date:  2015-04-29       Impact factor: 4.914

5.  The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.

Authors:  C Austin Zamarripa; Tanya Pareek; Hayley M Schrock; Thomas E Prisinzano; Bruce E Blough; Kenneth J Sufka; Kevin B Freeman
Journal:  Psychopharmacology (Berl)       Date:  2021-08-25       Impact factor: 4.530

Review 6.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 7.  The neuroanatomy of sexual dimorphism in opioid analgesia.

Authors:  Dayna R Loyd; Anne Z Murphy
Journal:  Exp Neurol       Date:  2014-04-13       Impact factor: 5.330

8.  Contribution of Endogenous Spinal Endomorphin 2 to Intrathecal Opioid Antinociception in Rats Is Agonist Dependent and Sexually Dimorphic.

Authors:  Arjun Kumar; Nai-Jiang Liu; Priyanka A Madia; Alan R Gintzler
Journal:  J Pain       Date:  2015-09-02       Impact factor: 5.820

9.  Plasticity of Signaling by Spinal Estrogen Receptor α, κ-Opioid Receptor, and Metabotropic Glutamate Receptors over the Rat Reproductive Cycle Regulates Spinal Endomorphin 2 Antinociception: Relevance of Endogenous-Biased Agonism.

Authors:  Nai-Jiang Liu; Vijaya Murugaiyan; Emiliya M Storman; Stephen A Schnell; Arjun Kumar; Martin W Wessendorf; Alan R Gintzler
Journal:  J Neurosci       Date:  2017-10-12       Impact factor: 6.167

10.  Sex differences in kappa opioid receptor antinociception is influenced by the number of X chromosomes in mouse.

Authors:  Anna M W Taylor; Caylin I Chadwick; Sadaf Mehrabani; Haley Hrncir; Arthur P Arnold; Christopher J Evans
Journal:  J Neurosci Res       Date:  2020-07-30       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.